Managing the patient presenting with xerostomia: a review

@article{Visvanathan2010ManagingTP,
  title={Managing the patient presenting with xerostomia: a review},
  author={Vikranth Visvanathan and Paul Nix},
  journal={International Journal of Clinical Practice},
  year={2010},
  volume={64}
}
Aims:  Patients complaining of a dry mouth can present themselves to various clinicians such as the primary care physician, dentists, otolaryngologists and/or oral surgeons. The aim of our review is to provide a systematic method of assessing and managing these patients based on current best evidence published in the literature. 
Diagnosis and management of xerostomia and hyposalivation
TLDR
The aim of this review is to investigate the current state of knowledge on management and treatment of patients affected by xerostomia and/or hyposalivation.
Xerostomia in head and neck malignancy.
TLDR
While the present management of radiotherapy-associated salivary dysfunction is challenging, there have been striking advances in preventative strategies and a number of possible treatment options may be over the near horizon.
Caring for patients with ‘dry mouth’
TLDR
The dental nurse is in an ideal position to help patients recognise dry mouth symptoms and help sufferers proactively manage their dry mouth condition.
Xerostomia: An Overview
(1) Background: Xerostomia is a subjective symptom of dry mouth resulting from various causes, including side effects of medication, systemic disorders, radiation, and Sjögren’s syndrome. Recently,
Xerostomia: current streams of investigation.
  • R. Quock
  • Medicine
    Oral surgery, oral medicine, oral pathology and oral radiology
  • 2016
TLDR
Approaches to treating and/or preventing salivary hypofunction in patients with these conditions will likely incorporate gene therapy, stem cell therapy, and tissue engineering.
Xerostomia: An Update of Causes and Treatments
TLDR
This chapter presents the relevant data about etiology of xerostomia, such as age, autoimmune diseases, systemic diseases, infectious diseases, neuropathic complications, psychogenic factors and therapeutically consumption of drugs among others, and the current available treatments.
Chapter 2 Xerostomia : An Update of Causes and Treatments
Xerostomia or dry mouth sensation is considered a complex condition that affects several stomatological functions that drives to the detriment of the quality of life of individuals who suffer from
Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs.
TLDR
A systematic approach to xerostomia management can facilitate interdisciplinary patient care, including collaboration with physicians regarding systemic conditions and medication use, and emphasize patient education and lifestyle modifications.
Dry mouth: a critical topic for older adult patients.
TLDR
A summary of the etiology, diagnosis, prevention, and pharmacological and non-pharmacological treatment of dry mouth (salivary hypofunction and xerostomia in older adults).
Common Oral Conditions in Children with Special Needs
TLDR
Dental professionals have a paramount role in enhancing the patient's quality of life through management of the oral issues as well as in educating caretakers and allied health professionals.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 33 REFERENCES
Subjective reports of xerostomia and objective measures of salivary gland performance.
TLDR
This study examines which questions are useful in identifying and predicting current major salivary gland output deficiency or dysfunction and collects saliva under unstimulated and stimulated conditions and asks standardized questions of 100 patients with xerostomia.
Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction.
TLDR
In appropriate patients, pilocarpine is a safe, easily administered, effective therapy to relieve xerostomia by increasing natural salivary function.
Xerostomia: A Prevalent Condition in the Elderly
Although xerostomia is associated with aging, studies have determined that salivary gland function is well preserved in the healthy geriatric population. Therefore, dry mouth is probably not a
Xerostomia in patients with advanced cancer.
TLDR
Xerostomia was the fourth most common symptom and was associated with a poor performance status, and its severity was correlated with the severity of oral discomfort, dysgeusia, dysmasesia, dysphagía, dysphonia, and anorexia.
Xerostomia. Part II: Relationship to nonoral symptoms, drugs, and diseases.
TLDR
The data show that xerostomia and several other oral symptoms are valid indicators of salivary gland hypofunction and suggest, moreover, that select nonoral symptoms are an indicator of generalized xerosis.
Oral Health Status and Dental Needs in a Geriatric Institutionalized Population in Paris1
TLDR
Residents of a geriatric hospital in France were given an oral exam and interviewed by questionnaire regarding their backgrounds, physical health and oral hygiene habits and there were significant amounts of root and cervical caries in spite of the relatively high level of oral health care provided by the staff.
A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study.
TLDR
In patients with pretreatment stimulated saliva volumes greater than resting saliva volumes, a positive response to subsequent use of the sialagogue was seen and Bethanechol (25 mg, three times daily) was not associated with significant side effects.
The influence of xerostomia after radiotherapy on quality of life
TLDR
Quality of life was influenced by T classification, clinical stage, a higher radiation dose or the use of concomitant chemotherapy, but was independent of the interval since the end of radiotherapy.
Adverse drug reactions in the mouth.
TLDR
The present report details the more common and significant adverse oral consequences of drug therapy and, when relevant, provides sources of other suitable reports; it does not include details of the oral side effects of foodstuffs, tobacco, alcohol, or recreational drugs, nor the adverse effect of drugs upon the dentition.
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
TLDR
Treatment with cevimeline at a dosage of 30 mg 3 times daily resulted in substantive improvement by increasing the rate of saliva and tear flow in patients with Sjögren's syndrome, as well as improving subjective symptoms of dry mouth, dry eyes, and overall dryness.
...
1
2
3
4
...